Medicine and Dentistry
Adenomyosis
25%
Adnexa
12%
Adnexal Mass
16%
Adverse Event
11%
Age
22%
Aging
10%
Analysis
29%
Angioleiomyoma
16%
Assessment
16%
Association
21%
Breast Cancer
9%
Case Report
11%
Chemotherapeutic Agent
10%
Complication
12%
Computer Assisted Tomography
40%
Diagnosis
21%
Diagnostic Performance
10%
Dienogest
14%
Disease
11%
Electrical Impedance Tomography
9%
Endometriosis
33%
Endometrium
11%
Experience
23%
Fertility Preservation
20%
Follow up
14%
Gynecologic Disease
24%
Gynecological Surgery
10%
Hospital
11%
Hysterectomy
11%
Incision
20%
Inpatient
19%
Insulin Resistance
23%
Myoma
23%
Neoplasm
11%
Operation Duration
9%
Ovarian Reserve
15%
Pain
13%
Patient
93%
Pelvis
14%
Polycystic Ovary Syndrome
34%
Postoperative Pain
11%
Premenopause
10%
Sacrocolpopexy
12%
Surgery
64%
Triacylglycerol
17%
Uterine Artery Embolization
20%
Uterine Myomectomy
30%
Uterus
16%
Uterus Bleeding
18%
Woman
100%
Biochemistry, Genetics and Molecular Biology
Age
20%
Aging
11%
Association
28%
BRCA1
9%
C-Reactive Protein
7%
Cadmium
9%
Chromogenic In Situ Hybridization
9%
Chromosomal Aberration
9%
Cisplatin
9%
Cross Sectional Study
5%
FOXO3
9%
Gene Polymorphism
9%
Genome-Wide Association Study
6%
Glucose
9%
Glucose Metabolism
9%
Haplotype
9%
Human
9%
Impaired Glucose Tolerance
7%
Insulin
8%
Insulin Resistance
9%
Lipid Storage
7%
Mouse
19%
Nested Gene
16%
Ovarian Reserve
11%
Premenopause
9%
Single Nucleotide Polymorphism
9%
Triglyceride
8%
Pharmacology, Toxicology and Pharmaceutical Science
4,4' Isopropylidenediphenol
14%
Actaea racemosa
14%
Adverse Event
11%
Anaphylaxis
9%
Cadmium
19%
Cisplatin
9%
Comorbidity
9%
Dienogest
14%
Diethylstilbestrol
6%
Diseases
5%
Drug
9%
Endocrine Disruptor
5%
Endometriosis
19%
Gynecologic Disease
10%
Hormone
7%
Hypericum perforatum
9%
Insulin Resistance
9%
Menopausal Syndrome
9%
Misoprostol
9%
Mouse
9%
Muellerian Inhibiting Factor
9%
Obesity
9%
Phthalic Acid
11%
Premature Ovarian Failure
11%